AI assistant
EXOZYMES INC. — Director's Dealing 2024
Nov 19, 2024
34055_dirs_2024-11-18_04e27ef4-0f96-4e25-9545-4774a2cfb9e6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Invizyne Technologies Inc (IZTC)
CIK: 0002010788
Period of Report: 2024-11-08
Reporting Person: DIGIANDOMENICO ANTHONY (Director, 10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3808476 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| SAFE for Common Stock | $6.40 | 2024-11-30 | Common Stock (122657) | Indirect | |
| Warrant for Common Stock | $2.44 | 2025-06-22 | Common Stock (205293) | Indirect | |
| Stock Options for Common Stock | $2.44 | 2028-01-31 | Common Stock (25970) | Direct |
Footnotes
F1: Shares are held by MDB Capital Holdings, LLC, over which the Reporting Person has voting and dispositive authority. The Reporting Person disclaims any interest in the shares except to the extent of his pecuniary interests in MDB Capital Holdings, LLC.
F2: The SAFE converts into Common Stock upon the closing of a public offering of IZTC's securities. The Reporting Person disclaims any interest in the shares except to the extent of his pecuniary interests in MDB Capital Holdings, LLC.
F3: The warrant is held by MDB Capital Holdings, LLC and is exercisable at $2.44, until June 22, 2025. The Reporting Person disclaims any interest in the shares underlying the warrant except to the extent of his pecuniary interest in MDB Capital Holdings, LLC.
F4: The shares underlying the grant vest at the rate of 1,299 shares each quarter and are fully vested on January 31, 2026.